Natco Pharma receives Establishment Inspection Report for Chennai facility

25 Aug 2016 Evaluate

Natco Pharma has received successful Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for the inspection conducted, during the period February 8 - February 12, 2016, at its Chemical Division, Chennai, India (named Natco Organics, prior to amalgamation into the company).

The company has recently received successful EIR during the period February 29 to March 7, 2016 from the USFDA for the inspection conducted at its drug manufacturing facility in Kothur Village, Mahaboob Nagar District, Telangana.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.



Natco Pharma Share Price

917.90 3.05 (0.33%)
19-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.10
Dr. Reddys Lab 1278.90
Cipla 1517.00
Zydus Lifesciences 919.85
Lupin 2125.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×